The Outcome of Subtotal Parathyroidectomy for the Treatment of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

Authors:
  • RDRueben David
    Rueben David
  • VPVenkateswaran Parameswaran
    Venkateswaran Parameswaran
  • TGTim M. Greenaway
    Tim M. Greenaway
  • JSJoseph J. Shepherd
    Joseph J. Shepherd

Abstract
THE ROLE of parathyroidectomy in the management of sporadic primary hyperparathyroidism (PHPT) is well established. The cure rate exceeds 90%.1 Persistent and recurrent PHPT after operation usually occurs in the presence of multiple gland parathyroid disease, multiple adenomas, or diffuse hyperplasia of the parathyroid glands.2,3 Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant condition typified by hyperplasia of the parathyroid glands, gastroenteropancreatic neuroendocrine neoplasia, and pituitary neoplasia.4-6 Primary hyperparathyroidism is the most prevalent abnormality in MEN 1, occurring in virtually all persons who inherit the underlying gene defect.6 Hypercalcemia is often the first manifestation of MEN 1; biochemical disease usually becomes detectable during the second or third decade of life. The optimal timing and type of parathyroidectomy for patients with MEN 1, however, remain controversial.

This publication has 12 references indexed in Scilit: